Literature DB >> 14986032

Circulating matrix metalloproteinase-9 is transiently elevated after colorectal surgery.

I H J T de Hingh1, E T Waas, R M L M Lomme, T Wobbes, T Hendriks.   

Abstract

BACKGROUND AND AIMS: Plasma levels of matrix metalloproteinases (MMPs) may yield important information in patients suffering from colorectal cancer but the effect of surgery, a common treatment modality in these patients, on circulating MMP levels is currently unknown. The aim of this study was to assess whether plasma MMP-2 and MMP-9 levels are affected by operative procedures.
MATERIALS AND METHODS: In total 128 patients undergoing elective surgery for colorectal cancer (n = 66), liver metastases from colorectal origin (n = 50) and arthrosis of the hip (n = 12) were included in the study. Gelatinase activity was measured, using quantitative gelatin zymography, in plasma obtained before operation and 1 week, 1 month and 3 months postoperatively.
RESULTS: One week after operation a significant increase in proMMP-9 activity was measured after colorectal surgery (260%, p = 0.0038), liver surgery (285%, p < 0.0001) and hip surgery (217%, p = 0.012) as compared with preoperative levels. After 1 month proMMP-9 activity had returned to preoperative levels. No effect on proMMP-2 activity was measured.
CONCLUSION: Operative procedures have a profound but transient effect on plasma MMP-9 activity. If used to assess disease status, postoperative plasma MMP levels should be interpreted with caution. Copyright 2004 Springer-Verlag

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14986032     DOI: 10.1007/s00384-004-0578-4

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  18 in total

Review 1.  Matrix metalloproteinases.

Authors:  H Nagase; J F Woessner
Journal:  J Biol Chem       Date:  1999-07-30       Impact factor: 5.157

Review 2.  Matrix metalloproteinases in wound repair (review).

Authors:  L Ravanti; V M Kähäri
Journal:  Int J Mol Med       Date:  2000-10       Impact factor: 4.101

Review 3.  Regulation of matrix metalloproteinase expression in tumor invasion.

Authors:  J Westermarck; V M Kähäri
Journal:  FASEB J       Date:  1999-05       Impact factor: 5.191

4.  Matrix metalloproteinase 9 level predicts optimal collagen deposition during early wound repair in humans.

Authors:  M S Agren; L N Jorgensen; M Andersen; J Viljanto; F Gottrup
Journal:  Br J Surg       Date:  1998-01       Impact factor: 6.939

5.  High preoperative plasma tissue inhibitor of metalloproteinase-1 levels are associated with short survival of patients with colorectal cancer.

Authors:  M N Holten-Andersen; R W Stephens; H J Nielsen; G Murphy; I J Christensen; W Stetler-Stevenson; N Brünner
Journal:  Clin Cancer Res       Date:  2000-11       Impact factor: 12.531

6.  The plasminogen activator and matrix metalloproteinase systems in colorectal cancer: relationship to tumour pathology.

Authors:  E A Baker; D J Leaper
Journal:  Eur J Cancer       Date:  2003-05       Impact factor: 9.162

7.  Postsurgical wound progression monitored by temporal changes in the expression of matrix metalloproteinase-9.

Authors:  J F Tarlton; C J Vickery; D J Leaper; A J Bailey
Journal:  Br J Dermatol       Date:  1997-10       Impact factor: 9.302

Review 8.  Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets.

Authors:  Pia Vihinen; Veli-Matti Kähäri
Journal:  Int J Cancer       Date:  2002-05-10       Impact factor: 7.396

9.  Matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and tumour necrosis factor alpha release during cardiopulmonary bypass.

Authors:  H F Galley; G D Macaulay; N R Webster
Journal:  Anaesthesia       Date:  2002-07       Impact factor: 6.955

10.  Tissue levels of active matrix metalloproteinase-2 and -9 in colorectal cancer.

Authors:  E T Waas; R M L M Lomme; J DeGroot; Th Wobbes; T Hendriks
Journal:  Br J Cancer       Date:  2002-06-17       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.